Studies on the effects of bradykinin and its fragments on the central nervous system. 1979

K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
May 1970, Nutrition reviews,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
March 2022, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
August 2013, Current neurovascular research,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
February 2005, Current sports medicine reports,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
January 1982, Advances in biochemical psychopharmacology,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
May 1984, Neurologic clinics,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
January 1986, Acta physiologica et pharmacologica Bulgarica,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
October 1978, Biulleten' eksperimental'noi biologii i meditsiny,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
January 1956, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
K Kariya, and H Okamoto, and H Iwaki, and A Hashimoto, and M Yagyu, and Y Tsuchiya, and Y Okada
June 2022, Healthcare (Basel, Switzerland),
Copied contents to your clipboard!